Company profile for aTyr Pharma

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

aTyr’s mission is to translate newly discovered biological pathways to develop innovative therapeutics with improved outcomes for patients. Our focus is on the extracellular functionality and signalling pathways of tRNA synthetases. Built on more than a decade of foundational science in this area, we have built a global intellectual property estate directed to all 20 human tRNA synthetases, with over 300 protein compositions...
aTyr’s mission is to translate newly discovered biological pathways to develop innovative therapeutics with improved outcomes for patients. Our focus is on the extracellular functionality and signalling pathways of tRNA synthetases. Built on more than a decade of foundational science in this area, we have built a global intellectual property estate directed to all 20 human tRNA synthetases, with over 300 protein compositions patented.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
U.S.A
Address
Address
3545 John Hopkins Court, Suite #250 San Diego CA 92121
Telephone
Telephone
(858) 731-8389
youtube
YouTube

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Default Event

DDL Conference

Not Confirmed

envelop Contact Supplier

DDL Conference

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.globenewswire.com/news-release/2025/11/10/3184520/0/en/aTyr-Pharma-to-Present-at-Piper-Sandler-37th-Annual-Healthcare-Conference.html

GLOBENEWSWIRE
10 Nov 2025

https://www.globenewswire.com/news-release/2025/11/06/3183054/0/en/aTyr-Pharma-Announces-Third-Quarter-2025-Results-and-Provides-Corporate-Update.html

GLOBENEWSWIRE
06 Nov 2025

https://www.pharmiweb.com/press-release/2025-10-10/rosen-law-firm-urges-atyr-pharma-inc-nasdaq-atyr-stockholders-with-losses-in-excess-of-100k-to

PHARMIWEB
10 Oct 2025

https://www.globenewswire.com/news-release/2025/09/30/3158359/0/en/aTyr-Pharma-Presents-Additional-Findings-from-Phase-3-EFZO-FIT-Study-in-Late-Breaking-Oral-Abstract-at-the-European-Respiratory-Society-ERS-Congress-2025.html

GLOBENEWSWIRE
30 Sep 2025

https://www.globenewswire.com/news-release/2025/09/17/3151771/0/en/Foundation-for-Sarcoidosis-Research-Reacts-to-the-Announcement-of-aTyr-Pharma-s-Phase-3-Clinical-Trial-Results.html

GLOBENEWSWIRE
17 Sep 2025

https://www.reuters.com/business/healthcare-pharmaceuticals/atyr-hits-record-low-lung-disease-drug-fails-late-stage-trial-2025-09-15/

REUTERS
16 Sep 2025

REF. STANDARDS & IMPURITIES

Upload your portfolio for free, ask us

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty